PharmiWeb.com - Global Pharma News & Resources
18-Apr-2019

Elanix Biotechnologies AG: NOMINATION OF THE CHAIRMAN OF THE SUPERVISORY BOARD, THE VICE CHAIRMAN AND MEMBERS OF THE BOARD.

Elanix Biotechnologies AG / Key word(s): Personnel
Elanix Biotechnologies AG: NOMINATION OF THE CHAIRMAN OF THE SUPERVISORY BOARD, THE VICE CHAIRMAN AND MEMBERS OF THE BOARD.

18-Apr-2019 / 09:30 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


ELANIX BIOTECHNOLOGIES AG: NOMINATION OF THE CHAIRMAN OF THE SUPERVISORY BOARD, THE VICE CHAIRMAN AND MEMBERS OF THE BOARD.

Berlin, April 18 2019 - The Supervisory Board of Elanix Biotechnologies AG ("Company", "Elanix") has nominated by juridical order Professor Zhanfeng Cui and Anja Silling to become members of the Supervisory Board with immediate effect.

Today, the Supervisory Board of Elanix has nominated Anja Silling to become the Chairman of the Board and Fang Bao, an existing member of the board, to be the Vice Chairman.

Lee Ann Laurent-Applegate
CEO


18-Apr-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Elanix Biotechnologies AG
Stadthausbr├╝cke 1-3
20355 Hamburg
Germany
Phone: +41 22 363 66 40
Fax: +41 22 363 66 41
E-mail: info@elanix-bt.com
Internet: www.elanixbiotechnologies.com
ISIN: DE000A0WMJQ4
WKN: A0WMJQ
Listed: Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 801589

 
End of Announcement DGAP News Service

Editor Details

Last Updated: 18-Apr-2019